McDonald W I, Compston A, Edan G, Goodkin D, Hartung H P, Lublin F D, McFarland H F, Paty D W, Polman C H, Reingold S C, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker B Y, Wolinsky J S
Royal College of Physicians, London, United Kingdom.
Ann Neurol. 2001 Jul;50(1):121-7. doi: 10.1002/ana.1032.
The International Panel on MS Diagnosis presents revised diagnostic criteria for multiple sclerosis (MS). The focus remains on the objective demonstration of dissemination of lesions in both time and space. Magnetic resonance imaging is integrated with dinical and other paraclinical diagnostic methods. The revised criteria facilitate the diagnosis of MS in patients with a variety of presentations, including "monosymptomatic" disease suggestive of MS, disease with a typical relapsing-remitting course, and disease with insidious progression, without clear attacks and remissions. Previously used terms such as "clinically definite" and "probable MS" are no longer recommended. The outcome of a diagnostic evaluation is either MS, "possible MS" (for those at risk for MS, but for whom diagnostic evaluation is equivocal), or "not MS."
国际多发性硬化诊断小组提出了多发性硬化(MS)的修订诊断标准。重点仍然是客观证明病变在时间和空间上的播散。磁共振成像与临床及其他临床辅助诊断方法相结合。修订后的标准有助于诊断具有各种表现的MS患者,包括提示MS的“单症状”疾病、具有典型复发-缓解病程的疾病以及隐匿性进展、无明显发作和缓解的疾病。不再推荐使用以前使用的术语,如“临床确诊”和“可能的MS”。诊断评估的结果为MS、“可能的MS”(适用于有MS风险但诊断评估不明确的患者)或“非MS”。